CODEX DNA INC (DNAY) Stock Income Statement
NASDAQ:DNAY - Nasdaq - US1920031010 - Common Stock - Currency: USD
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 21.04M | 11.04M | 6.58M | 4.80M | |||
| Cost Of Goods | 11.01M | 6.74M | 2.95M | 2.68M | |||
| Gross Profit | 10.03M | 4.30M | 3.63M | 2.13M | |||
| Operating Expenses | 60.73M | 39.67M | 19.99M | 9.10M | |||
| Research and Development | 24.65M | 14.55M | 8.93M | 3.32M | |||
| Selling, General, and Administrative Expenses | 36.08M | 25.13M | 11.06M | 5.79M | |||
| Operating Income | -50.70M | -35.37M | -16.36M | -6.98M | |||
| Interest Income/Expense | -1.33M | -2.89M | -1.57M | -1.43M | |||
| Other Income/Expense | -51.00K | -62.00K | -74.00K | 102.00K | |||
| Non Recurring Items | -727.00K | -618.00K | N/A | N/A | |||
| Income Before Taxes | -52.81M | -38.94M | -18.00M | -8.30M | |||
| Income Tax | 22.00K | 14.00K | 5.00K | 0.00 | |||
| Net Income | -52.83M | -38.96M | -18.01M | -8.30M | |||
| EBITDA | -49.25M | -34.47M | -15.49M | -6.12M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -1.80 | -2.14 | -0.62 | -0.28 | |||
| Non GAAP EPS | -1.80 | N/A | N/A | N/A | |||
| Statistics | |||||||
| Gross Profit Margin | 47.67% | 38.93% | 55.12% | 44.29% | |||
| Profit Margin | -251.05% | -352.78% | -273.87% | -172.78% | |||
| Operating Profit Margin | -240.91% | -320.33% | -248.80% | -145.18% | |||
All data in USD